Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-27T07:31:42.414Z Has data issue: false hasContentIssue false

Safety of Trazodone in Older People. an Observational Study in Nursing Homes.

Published online by Cambridge University Press:  15 April 2020

A. Riolo
Affiliation:
Department of Mental Health, ASS 1 Triestina, Trieste, Italy
A. Zangrando
Affiliation:
Department of Mental Health, ASS 1 Triestina, Trieste, Italy
F. Babici
Affiliation:
Department of Mental Health, ASS 1 Triestina, Trieste, Italy
E. Pascolo-Fabrici
Affiliation:
Department of Mental Health, ASS 1 Triestina, Trieste, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The evaluation of safety represents the our interest, especially with references to older people that receive at the same time many drugs for psychiatric disorders and physical diseases. The polypharmacy between older people is a frequent phenomenon but little is know about adverse effects of antidepressants.

Method

We have examined the prescriptions in 10 nursing homes to collect adverse effects, included cause mortality, during a follow up of 2 years.

Results

The incidence of adverse events with Trazodone is very low, as so compared to other antidepressants. Also, older people, are a special population with high comorbidity. Still it is very difficult to reduce the recurrence to polypharmacy in these field but we must become integrated with general practitioners and other specialists.

Type
Article: 1600
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.